Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
G.ST Antivirals logo — Going after the viral Achilles' heel

G.ST Antivirals

Going after the viral Achilles' heel

Founded 2019 Austria Austria 11 employees Series A Total: $8.70M Biotechnology, Life Sciences

General Information

Company Name G.ST Antivirals
Founded Year 2019
Location Austria Austria +2
Employees 11
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

Get notified when G.ST Antivirals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About G.ST Antivirals

G.ST Antivirals

Slogan: "Going after the viral Achilles' heel"

Description: G.ST Antivirals applies an innovative host cell-based strategy to develop broad-spectrum antivirals against infections of the respiratory tract.

Founded: 2019

Industries: Biotechnology

Headquarter: Austria

Last Investment: €6.20M Series A investment at 25 January 2024

Last Investment Investors: Lansdowne Partners, xista science ventures

G.ST Antivirals, a biotechnology startup founded in 2019 and based in Austria, has recently secured a €6.20M Series A investment on 25 January 2024 from prominent investors Lansdowne Partners and xista science ventures. The company's innovative host cell-based strategy aims to develop broad-spectrum antivirals targeting respiratory tract infections, manifesting their slogan "Going after the viral Achilles' heel." With this latest investment, G.ST Antivirals is poised to make significant strides in its mission to combat viral infections and revolutionize antiviral treatments.

Taxonomy: biotech, clinical-stage, antivirals, respiratory infections, host cell-based strategy, viral infections, viral Achilles' heel, broad-spectrum, clinical trials

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 2
Investor Investor
25 Jan 2024
Seed Round •••••• - 03 Nov 2021
Pre Seed Round •••••• 1
Investor
08 May 2020

G.ST Antivirals Alternatives & Competitors

G.ST Antivirals vs
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. United States

Antiva Biosciences, Inc. is a clinical stage biopharmaceutical company developing novel, topical the...

Series E
30 employees
Biotechnology, Health Care
G.ST Antivirals vs
Via Nova Therapeutics
Via Nova Therapeutics United States

An antiviral startup focusing on acute and subacute viral infections for which therapies are non-exi...

Series Unknown
2 employees
Biotechnology, Health and Wellness
G.ST Antivirals vs
Topelia
Topelia Australia

Topelia is developing and commercialising its proprietary Antiviral Triple Therapy (ATT) TPL1 for co...

1 employees
Health Care, Health and Wellness
Compare G.ST Antivirals vs Topelia
Also compare with: G.ST Antivirals vs Signia Therapeutics Signia Therapeutics

FAQ About G.ST Antivirals

Going after the viral Achilles' heel
G.ST Antivirals was founded in 2019.
G.ST Antivirals is headquartered in Austria.
G.ST Antivirals operates in the following industries: Biotechnology, Life Sciences.
G.ST Antivirals has approximately 11 employees.
G.ST Antivirals has completed 3 funding rounds, raising a total of $8.70M. The latest funding stage is Series A.
Top alternatives and competitors to G.ST Antivirals include Antiva Biosciences, Inc., Via Nova Therapeutics, Topelia, Signia Therapeutics, stoked bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
G.ST Antivirals and Antiva Biosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors G.ST Antivirals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy